CellRev is a biotechnology company focused on process intensification within cell manufacturing applications.
CellRev is a biotechnology company focused on process intensification within cell manufacturing applications. The company’s proprietary technology facilitates the transition from batch to continuous processing of adherent cells. It’s a disruptive new biomanufacturing approach that increases yield while decreasing operating costs and capital expenditure.A proprietary cell detachment process is complemented by a specially designed bioprocess; together, they pose an altogether unique cell manufacturing solution.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 17, 2022 | Seed | £1.75M | 2 |
Happiness Capital
|
— | Detail |
| Feb 16, 2021 | Seed | £1M | 6 | — | — | Detail |
| Sep 16, 2019 | Pre-seed | — | 2 |
Northstar Ventures
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Happiness Capital
|
Yes | Seed |
Allusion
|
— | Seed |
Northern Accelerator
|
— | Seed |
|
|
— | Seed |
North East Innovation Fund
|
— | Seed |
Northstar Ventures
|
— | Seed |
Orange Ventures
|
— | Seed |
Stephen Schmidt
|
— | Seed |
Innovate UK
|
— | Pre-seed |